EP Patent

EP1740188A1 — Use of ciclesonide for the treatment of respiratory diseases in a smoking patient

Assigned to Takeda GmbH · Expires 2007-01-10 · 19y expired

What this patent protects

This invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic smoking patients. The method comprisese the administration of a pharmaceutical composition comprising ciclesonide.

USPTO Abstract

This invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic smoking patients. The method comprisese the administration of a pharmaceutical composition comprising ciclesonide.

Drugs covered by this patent

Patent Metadata

Patent number
EP1740188A1
Jurisdiction
EP
Classification
—
Expires
2007-01-10
Drug substance claim
No
Drug product claim
No
Assignee
Takeda GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.